ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,142.11
-0.50%
Dow Jones
40,743.10
1.32%
Gold vs US Dollar
2,441.135
0.78%
Brent Oil
83.185
-1.37%
Bitcoin
63,577.20
-1.97%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Inhibikase Therapeutics Inc (IKT) Share Price

IKT Inhibikase Therapeutics Inc

1.37
-0.12 (-8.05%)
Last Updated: 15:09:32
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Inhibikase Therapeutics Inc NASDAQ:IKT NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.12 -8.05 1.37 1.37 1.46 1.55 1.37 1.47 1,939 14:09:32   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics 261k -19.03M -2.9380 -0.53 9.65M
 Type  Size  Price  Time  Units 
  100 1.37 14:09:32 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore IKT News
18/06/202422:27EDGAR2Form S-1 - General form for registration of securities under the Securities Act of 1933
17/06/202413:05GLOBEInhibikase Therapeutics Completes Enrollment of the Phase 2 ‘201’ Trial Evaluating Risvodetinib in Untreated Parkinson’s Disease
10/06/202421:20EDGAR2Form PRE 14A - Other preliminary proxy statements
10/06/202421:05EDGAR2Form 8-K - Current report
05/06/202413:05GLOBEInhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs
04/06/202421:11EDGAR2Form D - Notice of Exempt Offering of Securities
22/05/202413:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
Period
Draw mode
Data Downloads for IKT

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Inhibikase Therapeutics Inc Articles